RNA Interference Therapy for Chronic Hepatitis B Predicts the Importance of Addressing Viral Integration When Developing Novel Cure Strategies

Chronic hepatitis B infection remains a globally important cause of morbidity and mortality and has recently undergone a renaissance in therapeutic interest with increased pre-clinical and clinical testing of new drug classes. One of the first new classes in the clinic was RNA interference agents, w...

Descripción completa

Detalles Bibliográficos
Autores principales: Wooddell, Christine I., Gehring, Adam J., Yuen, Man-Fung, Given, Bruce D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065501/
https://www.ncbi.nlm.nih.gov/pubmed/33808298
http://dx.doi.org/10.3390/v13040581

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065501/
https://www.ncbi.nlm.nih.gov/pubmed/33808298
http://dx.doi.org/10.3390/v13040581

Ejemplares similares